A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Utsunomiya, Takafumi ^a   Tanaka, Atsushi ^a   Tatsumi, Kenichi ^a   Ezcurra, Diego ^b  

^a Japanese Institution for Standardizing Assisted Reproductive Technology   (Japan)

^b MERCK SERONO S A   (Switzerland)

Author keywords

Assisted reproductive techniques; Fertility agents; Follicle stimulating hormone; Injections; Ovulation induction; Patient satisfaction; Self administration

Indexed keywords

GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ARTICLE; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; INFERTILITY THERAPY; INJECTION SITE PAIN; LEARNING; MAJOR CLINICAL STUDY; MEDICAL DEVICE; NURSE; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COMFORT; PATIENT SATISFACTION; PHYSICIAN; PREFILLED PEN; QUESTIONNAIRE;

FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPINS; HUMANS; INJECTIONS; JAPAN; PAIN; PATIENT PREFERENCE; PATIENT SATISFACTION; QUESTIONNAIRES; RECOMBINANT PROTEINS; REPRODUCTIVE TECHNIQUES, ASSISTED; SELF ADMINISTRATION;

EID: 84869200561     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-93     Document Type: Article

References (29)

1. Oehninger S. Ovulation induction in IVF. Minerva Ginecol 2011, 63:137-156.
2. Oehninger S, Hodgen GD. Induction of ovulation for assisted reproduction programmes. Baillieres Clin Obstet Gynaecol 1990, 4:541-573. 10.1016/S0950-3552(05)80310-4, 2282742.
3. Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 2003, 20:153-214. 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30, 14584523.
4. Pang SC. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments. Expert Rev Med Devices 2005, 2:27-32. 10.1586/17434440.2.1.27, 16293025.
5. Somkuti SG, Schertz JC, Moore M, Ferrande L, Kelly E. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. Curr Med Res Opin 2006, 22:1981-1996. 10.1185/030079906X132604, 17022858.
6. Platteau P, Laurent E, Albano C, Osmanagaoglu K, Vernaeve V, Tournaye H, Camus M, Van Steirteghem A, Devroey P. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 2003, 18:1200-1204. 10.1093/humrep/deg234, 12773446.
7. Sedbon E, Wainer R, Perves C. Quality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in France. Reprod Biomed Online 2006, 12:298-303. 10.1016/S1472-6483(10)61001-2, 16569316.
8. Bassett RM, Driebergen R. Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. Reprod Biomed Online 2005, 10:169-177. 10.1016/S1472-6483(10)60937-6, 15823219.
9. Craenmehr E, Bontje PM, Hoomans E, Voortman G, Mannaerts BM. Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe. Reprod Biomed Online 2001, 3:185-189. 10.1016/S1472-6483(10)62033-0, 12513852.
10. Markle RL, King PJ, Martin DB. Characteristics of successful human chorionic gonadotrophin (hCG) administration in assisted reproduction [abstract]. Fertil Steril 2002, 78(Suppl 1):S71-S72.
11. Pang S, Kaplan B, Karande V, Westphal LM, Scott R, Givens C, Sacks P. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reprod Biomed Online 2003, 7:319-326. 10.1016/S1472-6483(10)61871-8, 14653893.
12. Alviggi C, Revelli A, Anserini P, Ranieri A, Fedele L, Strina I, Massobrio M, Ragni N, De PG. A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF). Reprod Biol Endocrinol 2007, 5:45. 10.1186/1477-7827-5-45, 2216030, 18053198.
13. Weckler. Post marketing surveillance analysis of the routine use of follitrophin alpha in a prefilled ready to use injection pen in ART [abstract]. Fertil Steril 2006, 86:S411.
14. Porter R, Kissel C, Saunders H, Keck C. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens. Curr Med Res Opin 2008, 24:727-735. 10.1185/030079908X273291, 18230195.
15. Weiss N. Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online 2007, 15:31-37. 10.1016/S1472-6483(10)60688-8, 17623531.
16. Dumas H, Panayiotopoulos P, Parker D, Pongpairochana V. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006, 6:5. 10.1186/1472-6823-6-5, 1618831, 17034628.
17. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999, 106:57-68.
18. Brunton S. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens. Diabetes Technol Ther 2008, 10:247-256. 10.1089/dia.2008.0287, 18715198.
19. Hanestad BR, Albrektsen G. Quality of life, perceived difficulties in adherence to a diabetes regimen, and blood glucose control. Diabet Med 1991, 8:759-764. 10.1111/j.1464-5491.1991.tb01696.x, 1838068.
20. Pfutzner A, Asakura T, Sommavilla B, Lee W. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv 2008, 5:915-925. 10.1517/17425247.5.8.915, 18713000.
21. Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998, 41:15-23. 10.1016/S0168-8227(98)00055-2, 9768368.
22. Sucic M, Galic E, Cabrijan T, Ivandic A, Petrusic A, Wyatt J, Mincheva N, Milicevic Z, Malone J. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres. Med Sci Monit 2002, 8:I21-I26.
23. Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med 2002, 17:243-252. 10.1046/j.1525-1497.2002.10905.x, 1495033, 11972720.
24. Schattner A, Bronstein A, Jellin N. Information and shared decision-making are top patients' priorities. BMC Health Serv Res 2006, 6:21. 10.1186/1472-6963-6-21, 1431526, 16507096.
25. Hovatta O, McVeigh E, Lass A, Homburg R. A large Northern European observational study of follitropin alpha filled-by-mass pre-filled pen. Reprod Biomed Online 2009, 18:502-508. 10.1016/S1472-6483(10)60126-5, 19400991.
26. DiMatteo MR. The physician-patient relationship: effects on the quality of health care. Clin Obstet Gynecol 1994, 37:149-161. 10.1097/00003081-199403000-00019, 8194205.
27. Chen LN, Quan S, Li H, Yang XP, Chen SM, Zhang XY, Lin L, Xing FQ, Chen SL, Wan ZJ, et al. Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:100-104.
28. Christianson MS, Barker MA, Schouweiler C, Lindheim SR. A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles. Curr Med Res Opin 2007, 23:865-870. 10.1185/030079907X178784, 17407643.
29. Rama Raju GA, Suryanarayana K, Jaya PG, Murali KK. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study. J Clin Pharm Ther 2008, 33:401-407. 10.1111/j.1365-2710.2008.00931.x, 18613858.